Status: Open Not Enrolling
Investigator: Jasleen Randhawa
Study Coordinator:
Phone:
Multicenter, randomized, open-label, crossover PK study of ASTX727 versus IV decitabine. Adult subjects who are candidates to receive IV decitabine will be randomized 1:1 to receive the ASTX727 tablet Daily×5 in Cycle 1 followed by IV decitabine ... Read more >
Status: Enrolling
Investigator: Sai ravi kiran Pingali
Study Coordinator: Syed Muhammad Saad
Phone: 281.276.5263
This randomized phase III trial studies rituximab after stem cell transplant and to see how well it works compared with rituximab alone in treating patients with in minimal residual disease-negative mantle cell lymphoma in first complete remissi ... Read more >
